Alibaba Group Holding Limited
Alibaba Group Holding Limited (BABAF) Financial Performance & Income Statement Overview
Explore the financials of Alibaba Group Holding Limited (BABAF), including yearly and quarterly data on income, cash flow, and balance sheets.
Alibaba Group Holding Limited (BABAF) Income Statement & Financial Overview
Review Alibaba Group Holding Limited BABAF income statement with detailed quarterly and annual figures.
| Metric | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|
| Revenue | $280.15B | $236.50B | $243.24B | $221.87B |
| Cost of Revenue | $162.52B | $144.03B | $146.11B | $148.10B |
| Gross Profit | $117.63B | $92.47B | $97.13B | $73.78B |
| Gross Profit Ratio | $0.42 | $0.39 | $0.40 | $0.33 |
| R&D Expenses | $14.66B | $14.18B | $13.37B | $14.09B |
| SG&A Expenses | $53.53B | $42.25B | $45.98B | $42.84B |
| Operating Expenses | $76.42B | $57.23B | $61.14B | $59.01B |
| Total Costs & Expenses | $238.95B | $201.26B | $207.25B | $207.11B |
| Interest Income | $11.15B | $18.61B | $0.00 | $0.00 |
| Interest Expense | $2.48B | $2.43B | $2.19B | $7.88B |
| Depreciation & Amortization | $2.06B | $1.65B | $1.79B | $2.08B |
| EBITDA | $59.001B | $54.02B | $36.56B | $19.81B |
| EBITDA Ratio | $0.21 | $0.23 | $0.15 | $0.09 |
| Operating Income | $41.20B | $35.25B | $35.99B | $14.77B |
| Operating Income Ratio | $0.15 | $0.15 | $0.15 | $0.07 |
| Other Income/Expenses (Net) | $13.25B | $14.70B | -$3.41B | -$4.92B |
| Income Before Tax | $54.45B | $49.95B | $32.58B | $9.85B |
| Income Before Tax Ratio | $0.19 | $0.21 | $0.13 | $0.04 |
| Income Tax Expense | $11.15B | $7.38B | $10.06B | $5.72B |
| Net Income | $49.13B | $44.03B | $24.39B | $3.37B |
| Net Income Ratio | $0.18 | $0.19 | $0.10 | $0.02 |
| EPS | $2.53 | $2.34 | $1.23 | $0.17 |
| Diluted EPS | $2.50 | $2.27 | $1.24 | $0.16 |
| Weighted Avg Shares Outstanding | $18.59B | $18.76B | $19.33B | $19.76B |
| Weighted Avg Shares Outstanding (Diluted) | $19.20B | $19.32B | $19.59B | $19.98B |
The company's financials show resilient growth, with revenue advancing from $221.87B in Q4 2024 to $280.15B in Q3 2025. Gross profit remained healthy with margins at 42% in Q3 2025 compared to 33% in Q4 2024. Operating income hit $41.20B last quarter, sustaining a consistent 15% margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at $59.001B. Net income rose to $49.13B, while earnings per share reached $2.53. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan